The Inflammation Syndrome: The Complete Nutritional Program to Prevent and Reverse Heart Disease, Arthritis, Diabetes, Allergies, and Asthma

Product Information

Inflammation is the immune system's response to harmful stimuli, such as pathogens, damaged cells, toxic compounds, or irradiation [ 1], and acts by removing injurious stimuli and initiating the healing process [ 2]. Inflammation is therefore a defense mechanism that is vital to health [ 3]. Usually, during acute inflammatory responses, cellular and molecular events and interactions efficiently minimize impending injury or infection. This mitigation process contributes to restoration of tissue homeostasis and resolution of the acute inflammation. However, uncontrolled acute inflammation may become chronic, contributing to a variety of chronic inflammatory diseases [ 4]. Polyarteritis nodosa can be very serious if it's not treated. The main treatment is steroid medicine, and sometimes other medicines that reduce the activity of the immune system. Inflammation may be behind much of what ails us, but healthy foods and supplements can quench the fires. Your morning stiffness may not yet qualify as arthritis, but it's likely a sign of inflammation simmering throughout your body. Other red flags include elevated blood sugar levels, high cholesterol levels, or a few extra pounds around the middle each of which may help set the stage for serious inflammatory diseases.

The hallmarks of neuropathic pain are chronic allodynia and hyperalgesia. Allodynia is defined as pain resulting from a stimulus that ordinarily does not elicit a painful response (e.g. light touch). Hyperalgesia is defined as an increased sensitivity to normally painful stimuli. Calder, PC. (2012). Omega‐3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? The treatment of children with multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 infection involves immunomodulatory therapies such as IVIG and steroids. Anakinra, an interleukin-1 receptor inhibitor, has also been used, but its effectiveness is not established yet. As optimal regimens for MIS-C remain unknown, we aimed to assess the effect of anakinra in reducing hospital stay in patients with MIS-C. Methods Our institutional protocols for MIS-C changed over the study period. Over time, anakinra was used earlier in the disease course in severe patients and some moderate patients. The decision to initiate anakinra, along with its dosing and duration, was based on institutional guidelines and consultation with a pediatric rheumatology specialist. Anakinra was administered subcutaneously or intravenously, with dosing tailored to the severity of the disease, ranging between 2 and 10 mg/kg/day or 100-400 mg/day with a maximum of 400 mg/day. Anakinra was typically given between the first and second echo. Treatment was subsequently tapered off by the time of discharge. Elisia I, et al. (2020). The effect of smoking on chronic inflammation, immune function and blood cell composition.Viner RM, Whittaker E. Kawasaki-like Disease: emerging complication during the COVID-19 pandemic. Lancet Jun 6. 2020;395(10239):1741–3. https://doi.org/10.1016/S0140-6736(20)31129-6. https://www.arthritis.org/health-wellness/healthy-living/nutrition/anti-inflammatory/anti-inflammatory-diet Cole et al. found that patients with MIS-C who were treated with infliximab in addition to IVIG were less likely to receive supplementary treatment, had a shorter duration of ICU length of stay, had decreased development of LV dysfunction, and demonstrated a more rapid decline in CRP levels [ 19] than those who were only given IVIG. Notably in this study, steroids were not used as part of the treatment. Comparatively, in our study almost every child received steroids whether they also received anakinra or not. Our findings showed no difference in CRP reduction, worsening LV function, or ICU length of stay between the two groups. These findings highlight the potential benefits of combining different therapies in certain cases, and further emphasize the importance of individualized treatment plans based on patient needs and characteristics. Anakinra

Takayasu arteritis is a type of vasculitis that mainly affects young women. It's very rare in the UK. Microbial structures known as pathogen-associated molecular patterns (PAMPs) can trigger the inflammatory response through activation of germline-encoded pattern-recognition receptors (PRRs) expressed in both immune and nonimmune cells [ 10, 11]. Some PRRs also recognize various endogenous signals activated during tissue or cell damage and are known as danger-associated molecular patterns (DAMPS) [ 11]. DAMPs are host biomolecules that can initiate and perpetuate a non-infectious inflammatory response [ 12]. Disrupted cells can also recruit innate inflammatory cells in the absence of pathogens by releasing DAMPs [ 13]. Consistent with the notion that COVID-19 induces a hyperimmune response, this cytokine overproduction may underlie the potential mechanism into the CNS, possibly via the crossing of BBB. Previous studies corroborated this indirect mechanism, where high autoantibodies levels are detected in the cerebrospinal fluid of COVID-19 patients with neurological manifestations ( 82– 86). It appears, therefore, that an indirect immune-mediated mechanism may represent a preferential gate to the brain. However, further research is warranted to clarify the various unknown autoantigens in the CNS that are targeted. Additionally, the hypoxic state in severe COVID-19 patients, especially those with acute respiratory distress syndrome, may cause oxygen deficiency and anaerobic metabolism to occur in the brain ( 87). This acid accumulation, in turn, leads to neuronal ischemia, interstitial edema, cerebral obstruction and vasodilatation, causing acute cerebrovascular disease and CNS injury ( 87). A report of intracerebral hemorrhage in COVID-19 patients points to the potential mechanism of endothelial impairment ( 88). Owing to the fact that ACE2 receptors are present in cerebrovascular endothelial cells and modulate blood pressure in the renin-angiotensin-aldosterone system, SARS-CoV-2 may target these receptors, disrupting the blood pressure leading to hypertension or hypotension ( 87– 89).Moura FA, et al. (2015). Lipoic acid: Its antioxidant and anti-inflammatory role and clinical applications. In the longest follow-up study to date (up to 9 months), persistent symptoms including fatigue (13.6%), anosmia or ageusia (13.6%), and brain fog (2.3%) were reported ( 62). About a third of patients also reported a decline in health-related quality of life due to COVID-19 compared to the baseline level ( 62). A 6-months study on 1733 COVID-19 patients yields similar results, with 76% of the patients had at least one symptom, with the commonest being fatigue, muscle weakness or sleep disturbances ( 63). The severity of disease and female gender were identified as risk factors for post-COVID-19 consequences ( 63). Another 3-months study on COVID-19 patients revealed that females were more susceptible to fatigue, post-activity polypnea and hair loss compared to males ( 64).